SCRS Grieves the Passing of President and Founder Christine Pierre
The SCRS team is deeply saddened to share that SCRS founder and president, Christine Pierre, passed away today. Christine was diagnosed with ocular melanoma in early 2017. After surgery and receiving a positive prognosis from her doctors, she returned to life as normal – perhaps with a bit more reverence for what it means to live. In the time after her diagnosis, Christine poured herself into shaping the next generation of leadership at SCRS; she positioned the organization for a successful 2018 Global Site Solutions Summit and created a succession plan to ensure that SCRS would continue to grow and thrive. In early 2018, we learned that Christine’s cancer metastasized to her liver. She entered a number of clinical trials that afforded her more time with loved ones. Outside of her family and friends, Christine’s greatest love was the dynamic organization she built. If there is a message she wanted to instill, it is the importance of the clinical research site industry. Christine dedicated almost three decades of her life to advancing the work and voice of clinical research sites. With this passion and vision, she conceptualized the first Site Solutions Summit in 2006 and founded the Society for Clinical Research Sites in 2012.
Christine was an industry leader in the site arena and has represented the site community globally through hundreds of speaking engagements and research articles published in her name. Her contribution to furthering the sustainability of clinical research sites is unmatched. Having grown from 12 attendees to almost 1,000, the Global Site Solutions Summit is now recognized as the leading conference representing clinical research sites and is just one component of the work she has contributed to advancing clinical research. In her honor, we will continue to work and live the mission of SCRS to unite the voice of the global clinical research site community for greater site sustainability. SCRS remains in steadfast dedication to the site community so that we can continue saving lives and improving the quality of life by delivering safe and effective medications to patients faster. A memorial service will be held:
Monday, October 29, 11:00am EDT
Our Lady of the Fields
Millersville, MD Visitation with the family will take place on the following dates:
Sunday, October 28, 1:00pm – 4:00pm EDT
Beall Funeral Home
Bowie, MD Monday, October 29, 10:00am – 11:00am EDT
Our Lady of the Fields
In lieu of flowers, please make a gift in memory of Christine Pierre to support the ongoing ocular melanoma research being conducted by her doctor, Geoff Gibney, at the Lombardi Comprehensive Cancer Center. Information can be found on the
Lombardi Giving Page
.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
